SPIA
TTPH

Steward Partners Investment Advisory’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-110
Closed -$13K – 2383
2017
Q4 		$13K Buy
110
+105
+2,100% +$13.4K ﹤0.01% 1286
2017
Q3 		$0 Buy
+5
New +$669 ﹤0.01% 1804

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Steward Partners Investment Advisory's TTPH Position: Q1 2018 in Review

Steward Partners Investment Advisory sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2018, closing a stake of 110 shares — an estimated $13K sold.

Steward Partners Investment Advisory first reported a position in TTPH in Q3 2017 and held it in 2 quarters. The position peaked at $13K in Q4 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q1 2018.

  • Steward Partners Investment Advisory reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 110 Tetraphase Pharmaceuticals, Inc. shares in Q1 2018, an estimated $13K.
  • Steward Partners Investment Advisory first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Tetraphase Pharmaceuticals, Inc. position peaked at $13K in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.